Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hlb Global Co., Ltd. (003580:KRX), powered by AI.
Hlb Global Co., Ltd. is currently trading at ₩1,642. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hlb Global Co., Ltd. on Alpha Lenz.
Hlb Global Co., Ltd.'s P/E ratio is -11.0.
“Hlb Global Co., Ltd. trades at a P/E of -11.0 (undervalued) with modest ROE of -9.1%. 3Y revenue CAGR of 31.0% highlights clear growth momentum.”
Ask for details →Hlb Global Co., Ltd. operates as a leading player in the biotechnology and pharmaceutical industry, primarily focusing on research, development, and commercialization of innovative healthcare solutions. The company is heavily involved in the oncology sector, developing state-of-the-art treatments designed to treat a variety of cancers. In addition to its core focus on biotech, Hlb Global Co., Ltd. has diversified its business model by engaging in engineering services, offering advanced solutions across different industrial applications. This diversification allows the company to maintain robust business stability while driving innovation in the healthcare sector. With strategic partnerships and a strong commitment to research excellence, Hlb Global Co., Ltd. plays a significant role in the market by contributing to advancements in medical technologies and expanding access to critical healthcare treatments. Its efforts reflect a broader goal of enhancing the quality of life through medical innovation and sustainable business practices.
“Hlb Global Co., Ltd. trades at a P/E of -11.0 (undervalued) with modest ROE of -9.1%. 3Y revenue CAGR of 31.0% highlights clear growth momentum.”
Ask for details →Hlb Global Co., Ltd. (ticker: 003580) is a company listed on KRX in the Industrials sector (Conglomerates). It has approximately 145 employees. Market cap is $83.2B.
The current price is ₩1,642 with a P/E ratio of -11.03x and P/B of 1.13x.
ROE is -9.09% and operating margin is -9.86%. Annual revenue is $100.3B.